Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01253928Phase 4Unknown
A Phase 4 trial of pioglitazone in end stage renal disease (ESRD), sponsored by Lausanne University Hospital. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01253928.